Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-21 · accession 0001209191-22-058611 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-23 | 2022-11-21 | IRWD | Emany Sravan Kumar | SVP, CFO | S - Sale | $11.56 | -6,578 | 78.4K | -8% | -$76.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-21 | S | D | 6,578 | $11.56 | 78,422 | D | — | — |